Skip to content
CancerIndex

Publication

Design, synthesis, and biological evaluation of selective estrogen receptor modulators (SERMs) as anticancer agents for ER-positive breast cancer.

Anurag Saini, C Mythri, Ripunjay Kalita, Agnikula Kshatriya Parvathi Singh, Sandeep Jat, Pramod Kumar, Sudhagar Selvaraju, Kalyan Kumar Sethi

Bioorganic & medicinal chemistryNov 1, 2026PMID 42585901doi:10.1016/j.bmc.2026.118763 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 10, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260910-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Globally, breast cancer stands as one of the primary causes of cancer related deaths. Among the types of breast cancer, estrogen receptor- positive (ER+) breast cancer accounts for the highest incidence and mortality worldwide. The present study emphasizes the design, synthesis, and biological…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.